- Home
- III vs NBTX Comparison
III vs NBTX Comparison
Compare III & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- III
- NBTX
- Stock Information
- Founded
- III 2006
- NBTX 2003
- Country
- III United States
- NBTX France
- Employees
- III N/A
- NBTX N/A
- Industry
- III Professional Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- III Consumer Discretionary
- NBTX Health Care
- Exchange
- III Nasdaq
- NBTX Nasdaq
- Market Cap
- III 176.6M
- NBTX 178.7M
- IPO Year
- III 2007
- NBTX 2020
- Fundamental
- Price
- III $3.97
- NBTX $3.58
- Analyst Decision
- III Buy
- NBTX Strong Buy
- Analyst Count
- III 1
- NBTX 1
- Target Price
- III $3.75
- NBTX $12.00
- AVG Volume (30 Days)
- III 134.1K
- NBTX 13.0K
- Earning Date
- III 03-06-2025
- NBTX 04-02-2025
- Dividend Yield
- III 4.60%
- NBTX N/A
- EPS Growth
- III N/A
- NBTX N/A
- EPS
- III 0.06
- NBTX N/A
- Revenue
- III $247,585,000.00
- NBTX $45,220,186.00
- Revenue This Year
- III N/A
- NBTX N/A
- Revenue Next Year
- III $5.20
- NBTX N/A
- P/E Ratio
- III $67.19
- NBTX N/A
- Revenue Growth
- III N/A
- NBTX 526.17
- 52 Week Low
- III $2.92
- NBTX $2.76
- 52 Week High
- III $4.18
- NBTX $7.51
- Technical
- Relative Strength Index (RSI)
- III 72.66
- NBTX 51.20
- Support Level
- III $3.59
- NBTX $3.32
- Resistance Level
- III $3.79
- NBTX $3.77
- Average True Range (ATR)
- III 0.13
- NBTX 0.19
- MACD
- III 0.04
- NBTX 0.01
- Stochastic Oscillator
- III 85.44
- NBTX 52.58
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.